The global sterile tubing welder market size was valued at over USD 2.24 billion in 2019 and is anticipated to expand at a CAGR of 4.6% over the forecast period. Increasing demand from end-use industries and a rise in investments in R&D projects are anticipated to drive the market for sterile tubing welder in the coming years. Furthermore, the rise in usage of single-use technologies and increasing demand for blood and blood products are anticipated to boost the market growth.
In U.S., nearly 20 million units of platelets, plasma, and red blood cells are transfused for treatment of hematologic conditions, such as sickle cell disease, severe anemia, and leukemia, annually. Such a high demand for blood products is anticipated to fuel the demand for blood processing, sterile processing, and related infrastructure.
Extensive and ongoing biopharmaceutical research on the development of innovative and therapeutically advanced medicines is anticipated to drive the market for sterile tubing welder in the forthcoming years. For instance, according to the report published by the Pharmaceutical Research and Manufacturers of America, nearly 8,000 medicines are in the development phase across the globe and around 74% of these pipeline drugs are anticipated to be First-in-class medicines. Some of the key therapeutic categories covered by these development medicines are genetic disorders, Amyotrophic lateral sclerosis, cancer, and hemophilia.
The hematology community has witnessed several advancements in the field of bio-engineering and high-tech cell therapies in the past decade. Development of techniques to isolate specialized cells from the blood, such as hematopoietic progenitor cells (HPC), has improved the extraction process and donor safety, thereby increasing demand for HPC transplantation and indirectly facilitating the demand for blood processing and sterile processing systems.
Demand for innovative and medically advanced sterile equipment, such as automated sterile tubing welders, is on the rise owing to wastage of collected blood due to contamination, inappropriate storage, blood bag leakages, and lack of proper handling facilities and skilled professionals.
The market for sterile tubing welder is segmented into automatic and manual on the basis of mode. In 2019, the automatic sterile tubing welder accounted for over 80% share of the overall revenue and is anticipated to witness substantial growth over the forecast period owing to its improved weld quality and user-friendliness.
Automatic sterile tubing welder offers higher weld speed and minimal setup time, thereby outpacing a skilled manual welder and reducing the dependency on human labor. Thus, increased output and reduced labor costs are anticipated to increase the demand for these sterile tubing welders.
Based on the application, the global sterile tubing welder market is segmented into biopharmaceutical, diagnostic laboratories, blood processing, and others. The blood processing segment held the largest market share in 2019 and is anticipated to witness lucrative growth over the forecast period.
Increasing demand for blood and blood products is anticipated to drive the segment. Moreover, high demand for personalized medicine, increasing cell and gene therapies, and the rising prevalence of blood disorders, such as hemophilia, are likely to boost segment growth. For instance, hemophilia is estimated to affect nearly 1,125,000 men across the globe.
Based on the end use, the market for sterile tubing welder is segmented into hospitals, blood centers, research clinics, and others. The hospital segment held the largest market share in 2019 and is anticipated to witness lucrative growth over the forecast period owing to the presence of advanced hematology related equipment in hospital settings. In addition, the availability of wide treatment options in such facilities has increased the number of visits for blood disorders diagnosis and treatments in these facilities.
Blood centers are anticipated to witness substantial growth over the forecast period. This can be attributed to an increase in the demand for blood and blood products for the treatment of various blood disorders, such as leukemia, thalassemia, and severe anemia. In addition, a rise in road accidents is anticipated to increase the demand for blood and blood products, thereby facilitating the segment growth.
In 2019, North America accounted for the largest share in terms of revenue. An increase in the prevalence of chronic diseases, recent technological advancements, and high demand for hygienic and sterile environments to avoid contamination are some of the major factors contributing to the growth of the market in this region.
The Asia Pacific is expected to witness significant growth over the forecast period. Increasing investments in research & development by major multinational companies in this region are boosting the growth of pharmaceutical and biopharmaceutical industries in the region.
Some of the key companies operating in the market for sterile tubing welder are Sartorius Stedim Biotech S.A.; Terumo BCT Inc.; GE Healthcare; MGA technologies; VANTE Biopharm; Genesis BPS; Biomen Biosystems Company Ltd.; Flex Concepts Inc.; and Shanghai Le Pure Biological Technology Co., Ltd. Mergers and acquisitions are the key strategies adopted by the market players. For instance, in 2017, Terumo acquired vascular closure business and certain assets of Abbott and St. Jude.
|
Attribute |
Details |
|
Base year for estimation |
2019 |
|
Actual estimates/Historical data |
2016 - 2018 |
|
Forecast period |
2020 - 2027 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 to 2027 |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America & MEA |
|
Country scope |
U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and UAE |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
|
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global sterile tubing welder market report on the basis of mode, application, end use, and region:
Mode Outlook (Revenue, USD Million, 2016 - 2027)
Manual
Automatic
Application Outlook (Revenue, USD Million, 2016 - 2027)
Biopharmaceutical
Blood Processing
Diagnostic Laboratories
Others
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Research Clinics
Blood Centers
Others
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
